This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
WASHINGTON — Five days after discovering their 16-year-old son Daniel Puerta unresponsive in bed, Jaime Puerta and his wife decided to discontinue life support as they stood beside him in the Los Angeles Children’s Hospital. Puerta kissed his son’s nose one last time. Daniel, who had no history of drug use, is one of countless stories tragically connected to the nation’s opioid crisis.
Peter Wells, CEO of TemperPack, discusses the life sciences industry's shift toward sustainable packaging, particularly in cold chain logistics, to replace outdated petroleum-based materials like expanded polystyrene (EPS). His insights cover the growing importance of sustainability as a business driver, emphasizing efficiency, waste reduction, regulatory pressures, and emerging innovations in biodegradable and recyclable packaging solutions.
Five years ago, the Covid-19 pandemic swept through the world, resulting in massive disruptions, including to biomedical researchers. As National Institutes of Health-funded physician-scientists, we collectively experienced the pitfalls of lab closures, pauses in clinical trial recruitment due to staffing issues and social distancing policies affecting in-person accrual, and redeployment away from research work to the frontlines to support clinical care.
Advances in the life sciences are driving a significant increase in the number of temperature-sensitive pharmaceuticals. The packaging industry is meeting the moment with advances of its own, including high-performance, environmentally-friendly materials that allow life science companies meet stringent thermal requirements and ambitious CO2e reduction goals.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Morning. Today, we’re taking a look at the profound impact of funding cuts on cancer research under the Trump administration. Also, venture investors are pivoting away from gene therapies and leaning into faster-return areas like obesity and cancer. Can philanthropy rescue struggling small biotechs? Small biotech startups drive most drug innovation in the U.S., but they’re getting squeezed by the drug industry’s anti-competitive tactics and a patent system that rewards
Two of the top four CMS deficiencies in Ambulatory Surgery Centers last year were related to medication management. As we know, medication management citations fall under various sections of the CMS requirements (Conditions For Coverage). There isnt just one single section on medications in the CMS document, so knowing your way around the requirements is essential to ensure compliance with each element of safe medication management.
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so-familiar routine of meetings, deadlines, and messages has returned. But what can you do? There is no pause button to stop the world from spinning. To cope, we are quaffing cups of stimulation. Our choice today is peppermint.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so-familiar routine of meetings, deadlines, and messages has returned. But what can you do? There is no pause button to stop the world from spinning. To cope, we are quaffing cups of stimulation. Our choice today is peppermint.
By Larry K. Houck In August 2023, the U.S. Department of Health and Human Services (HHS), based on the federal Controlled Substances Acts (CSAs) Eight Factor Analysis, recommended that the Drug Enforcement Administration (DEA) reschedule marijuana from schedule I to schedule III. The U.S. Department of Justice subsequently conducted a separate Eight Factor Analysis and concurred with HHS rescheduling recommendation.
23andMe said late Sunday it will file for bankruptcy and CEO and co-founder Anne Wojcicki will depart, after she repeatedly tried and failed to take the storied but financially troubled DNA-testing startup private. The company will now try to sell itself through a court-supervised sale. It closed Friday valued at a hair under $50 million, a calamitous fall from 2021, when it went public and soared to a nearly $6 billion market cap.
Innovative research suggests that a combination cleaning approach can reliably eliminate mycoplasma, viruses, and endotoxin contaminants in biosafety cabinets. The study proposed that wiping with various disinfectants (distilled water, ethanol, and benzalkonium chloride (BKC)), together with UV irradiation was optimal for changeover cleaning. Optimising contaminant removal in biosafety cabinets Mizuno et al. stated that their study is the first to provide reference data of different cleaning met
Small, early-stage biotech startups are the heart of drug innovation in the U.S. Growing anti-competitive challenges threaten their work, but philanthropy may offer an avenue forward. At the center of these challenges is the U.S. patent system and how it incentivizes anti-competitive behavior among the most powerful players. The argument is that patents — meant to spur innovation — are being gamed by drug manufacturers to extend monopoly profits and exclusivity, stifling competitio
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
In a world where innovation, regulation, and consumer behavior shift rapidly, keeping up with pharma news is not just helpfulits essential. For pharma marketing executives and their teams, staying current helps maintain competitive advantage, ensures compliance, and unlocks opportunities for smarter, faster campaign decisions. With new drug approvals, branded marketing trends, and policy updates emerging weekly, how can pharma marketers stay informed without becoming overwhelmed?
This is the online version of STAT’s email newsletter Health Care Inc., delivered to your inbox every Monday. Sign up here. Well hello, everyone! I’m out this week, which means my buddy Tara Bannow is going to be taking the helm of this newsletter next Monday. You know what to do: Send her all of your tips, gossip, and random musings at tara.bannow@statnews.com.
The pace of change in healthcare marketing has reached an all-time high. With new platforms, tools, privacy regulations, and patient behaviors evolving every week, teams that fail to adapt risk falling behind. This is especially true when it comes to developing modern pharma marketing strategies. In an industry where precision, compliance, and engagement are critical, staying agile and prepared is more important than ever.
Prominent outside scientists who help the National Institutes of Health evaluate its internal research programs are being abruptly removed, according to five advisers whose positions were terminated and a recording of an internal meeting obtained by STAT. The motivations behind the removals from the agency’s boards of scientific counselors remain unclear.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
How did 23andMe go bankrupt? The same way bankruptcy was described by Ernest Hemingway in 1926: “Two ways: Gradually, and then suddenly.” Since its founding in 2006, the company, which aimed to give consumers access to their genetic information, faced what seemed like one killing blow after another: questions of whether its business was ethical, the Food and Drug Administration blocking the sale of its tests, and, last year, a cyberattack in which hackers gained access to the recor
National Adverse Drug Event Awareness Day occurs annually on March 24 to raise awareness about minimizing the risk of adverse events caused by medications.
A new report by the Wall Street Journal reveals abuse of the 340B hospital markup program is getting worse as hospitals and middlemen find new ways to profit off the program.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Mark Garofoli, PharmD, BCGP, CPE, director of experiential learning at West Virginia University, discusses the potential of psuychedelic therapy in pharmacy.
National Adverse Drug Event Awareness Day was established to promote awareness, drive policy changes, and encourage health care professionals and patients to prioritize medication safety.
Emily Leppien, PharmD, BCPS, BCPP, clinical associate professor of pharmacy practice at Binghamton University, discusses identifying potential red flags for substance use disorder.
Heather Johnson, PharmD, BCACP, CTTS, and Heather Roth, BSPharm, RPh, discuss medications and devices used for improving cardiovascular health among patients with or without diabetes.
Match Day 2025 has come and gone with the largest-ever total of applicants and positions as well as upticks in primary care and emergency medicine. | Numbers released alongside Friday's big reveal for doctors-in-training brought encouraging news for an industry facing clinical workforce shortages.
Centers for Disease Control and Prevention (CDC) Acting Director Susan Monarez will be nominated by the White House to fill the role in a permanent capacity, according to multiple reports citing ad | The public health agency's current acting director has a background in biomedical research and 20 years of experience withing government bodies.
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! I’ve got a meaty issue for you here to start the week. Thanks so much for reading.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content